ATP12A Proton Pump as an Emerging Therapeutic Target in Cystic Fibrosis and Other Respiratory Diseases
Biomolecules · 2023
DOI: 10.3390/biom13101455 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2023. Verfasst von Michał Dębczyński und 5 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, 15-540 Bialystok, Poland. Hauptthemen laut MEDLINE: Cystic Fibrosis, Respiration Disorders, Respiratory Tract Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vertex Cystic Fibrosis Research Innovation Award, Italian Cystic Fibrosis Foundation, Italian Ministry of Health.
Abstract (Originalsprache)
ATP12A encodes the catalytic subunit of the non-gastric proton pump, which is expressed in many epithelial tissues and mediates the secretion of protons in exchange for potassium ions. In the airways, ATP12A-dependent proton secretion contributes to complex mechanisms regulating the composition and properties of the fluid and mucus lining the respiratory epithelia, which are essential to maintain the airway host defense and the respiratory health. Increased expression and activity of ATP12A in combination with the loss of other balancing activities, such as the bicarbonate secretion mediated by CFTR, leads to excessive acidification of the airway surface liquid and mucus dysfunction, processes that play relevant roles in the pathogenesis of cystic fibrosis and other chronic inflammatory respiratory disorders. In this review, we summarize the findings dealing with ATP12A expression, function, and modulation in the airways, which led to the consideration of ATP12A as a potential therapeutic target for the treatment of cystic fibrosis and other airway diseases; we also highlight the current advances and gaps regarding the development of therapeutic strategies aimed at ATP12A inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, 15-540 Bialystok, Poland.
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, 16132 Genoa, Italy.
- Unit of Medical Genetics, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
ORCID-Profile: Giulia Gorrieri, Damian Mojsak, Paolo Scudieri
Förderung
- Vertex Cystic Fibrosis Research Innovation Award
- Italian Cystic Fibrosis Foundation
- Italian Ministry of Health
Zitieren
APA
Dębczyński, M., Gorrieri, G., Mojsak, D., Guida, F., Zara, F., & Scudieri, P. (2023). ATP12A Proton Pump as an Emerging Therapeutic Target in Cystic Fibrosis and Other Respiratory Diseases. Biomolecules. https://doi.org/10.3390/biom13101455
Vancouver
Dębczyński M, Gorrieri G, Mojsak D, Guida F, Zara F, Scudieri P. ATP12A Proton Pump as an Emerging Therapeutic Target in Cystic Fibrosis and Other Respiratory Diseases. Biomolecules. 2023. doi:10.3390/biom13101455
BibTeX
@article{Dbczyski2023,
author = {Dębczyński, Michał and Gorrieri, Giulia and Mojsak, Damian and Guida, Floriana and Zara, Federico and Scudieri, Paolo},
title = {ATP12A Proton Pump as an Emerging Therapeutic Target in Cystic Fibrosis and Other Respiratory Diseases},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13101455}
}
EUVIMED